GeneDx Holdings (WGS) Long-Term Deferred Tax (2020 - 2021)
GeneDx Holdings' (WGS) quarterly Long-Term Deferred Tax came in at $426000.0 in Q1 2021, up 954.46% quarter-over-quarter from $40400.0 in Q4 2020.
Analysis
GeneDx Holdings (WGS) Long-Term Deferred Tax (2020 - 2021) Analysis & Trends
GeneDx Holdings (WGS) has reported Long-Term Deferred Tax for 2 consecutive years, with $426000.0 the latest figure, recorded in Q1 2021.
- On a quarterly basis, Long-Term Deferred Tax changed N/A year-over-year to $426000.0 in Q1 2021; TTM through Mar 2021 was $426000.0, a N/A change from a year earlier, with the FY2020 full-year figure at $40400.0, changed N/A from the prior year.
- Long-Term Deferred Tax was $426000.0 for Q1 2021 at GeneDx Holdings, up from $40400.0 in the prior quarter.
- Over five years, Long-Term Deferred Tax peaked at $426000.0 in Q1 2021 and troughed at $12000.0 in Q3 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn |
| 10 | GeneDx Holdings | 3.01 Bn | 2.88 Bn | 78.24 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2021 | 426,000.00 |
| Dec 31, 2020 | 40,400.00 |
| Sep 30, 2020 | 12,000.00 |